In order to test the clinical relevance of our findings, we stained by immunohistochemistry (IHC) 128 samples retrieved from 87 glioma patients for the expression of HIF-1α, TCF1, TCF4 and the neuronal marker βIII-tubulin. Here, TCF4 is linked to central nervous system cancer.